Callum Docherty
Hudson Institute of Medical Research, VIC, Australia
- This delegate is presenting an abstract at this event.
Presentations this author is a contributor to:
ADS032, the first dual NLRP1 and NLRP3 inflammasome inhibitor for the treatment of infectious and inflammatory diseases (#4)
2:50 PM
Ashley Mansell
Session 2: Innate Immunity